Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain)

Background: There is a worldwide over-prescription of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD), off-label prescribing, and unnecessary prescription of high doses. Objectives: Our aim was to assess the prescription rate of ICS and to identify sociode...

Descripción completa

Detalles Bibliográficos
Autores: Román-Rodríguez, Miguel, van Boven, Job F. M., Vargas, Freya, Contreras, Cecilia C., Lamelas, Gema, Gestoso, Salvador, Gongora, Miguel, Corredor Ibáñez, María Teresa, Esteva Cantó, Magdalena
Tipo de recurso: artículo
Fecha de publicación:2016
País:España
Institución:Conselleria de Salut i Consum del Govern de les Illes Balears
Repositorio:Docusalut
Idioma:inglés
OAI Identifier:oai:docusalut.com:20.500.13003/10515
Acceso en línea:https://hdl.handle.net/20.500.13003/10515
Access Level:acceso abierto
Palabra clave:Administration, Inhalation
Male
Aged, 80 and over
Asthma
Aged
Dose-Response Relationship, Drug
Spain
Adrenal Cortex Hormones
Pulmonary Disease, Chronic Obstructive
Humans
Smoking
Middle Aged
Cross-Sectional Studies
Spirometry
Primary Health Care
Regression Analysis
Female
Multivariate Analysis
Femenino
Análisis Multivariante
Administración por Inhalación
Masculino
Fumar
Estudios Transversales
Enfermedad Pulmonar Obstructiva Crónica
Relación Dosis-Respuesta a Droga
Humanos
Persona de Mediana Edad
Anciano
Asma
Anciano de 80 o más Años
Corticoesteroides
Atención Primaria de Salud
Análisis de Regresión
Espirometría
España
Chronic obstructive pulmonary disease
treatment
inhaled corticosteroids
primary care
quality of healthcare
id ES_7d02cefbd581dd15260dc847fdc30e29
oai_identifier_str oai:docusalut.com:20.500.13003/10515
network_acronym_str ES
network_name_str España
repository_id_str
spelling Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain)Román-Rodríguez, Miguelvan Boven, Job F. M.Vargas, FreyaContreras, Cecilia C.Lamelas, GemaGestoso, SalvadorGongora, MiguelCorredor Ibáñez, María TeresaEsteva Cantó, MagdalenaAdministration, InhalationMaleAged, 80 and overAsthmaAgedDose-Response Relationship, DrugSpainAdrenal Cortex HormonesPulmonary Disease, Chronic ObstructiveHumansSmokingMiddle AgedCross-Sectional StudiesSpirometryPrimary Health CareRegression AnalysisFemaleMultivariate AnalysisAged, 80 and overFemeninoAnálisis MultivarianteAdministración por InhalaciónMasculinoFumarEstudios TransversalesEnfermedad Pulmonar Obstructiva CrónicaRelación Dosis-Respuesta a DrogaHumanosPersona de Mediana EdadAncianoAsmaAnciano de 80 o más AñosCorticoesteroidesAtención Primaria de SaludAnálisis de RegresiónEspirometríaEspañaChronic obstructive pulmonary diseasetreatmentinhaled corticosteroidsprimary carequality of healthcareBackground: There is a worldwide over-prescription of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD), off-label prescribing, and unnecessary prescription of high doses. Objectives: Our aim was to assess the prescription rate of ICS and to identify sociodemographic and clinical factors associated with ICS prescription among patients with COPD, treated in Balearic primary healthcare. Methods: This cross-sectional study included all patients with a clinical COPD diagnosis, who attended a primary care centre of the Balearic Islands (Spain) during 2012. Also, a sub-population with spirometry-confirmed COPD was defined. Data were obtained on patient demographics, smoking status, spirometry, ICS prescriptions, other respiratory medication, exacerbations and comorbidities. Associations with ICS and high-dose ICS prescription were assessed using multivariate regression analyses. Results: In total, 15,440 patients were included (70% men, mean age 68.6 years), and 44.6% were prescribed ICS. The largest association with ICS prescription was asthma comorbidity (OR: 3.50; 95%CI: 3.12-3.92), followed by exacerbation history (OR: 2.23; 95%CI: 2.07-2.47). In addition, smoking status, spirometry, atopic dermatitis, allergic rhinitis and mean age were significantly (P<0.001) associated with ICS treatment. In the spirometry-confirmed population, asthma (OR: 2.89; 95%CI: 2.29-3.64) and exacerbations were also the major factors (OR: 2.85; 95%CI: 2.45-3.32) followed by severe bronchial-obstruction (OR: 2.63; 95%CI: 2.24-3.08). High-dose ICS prescription was mainly associated with severe obstruction (OR: 2.27; 95%CI: 1.93-2.68). Conclusion: The percentage of COPD patients prescribed ICS in Balearic primary care is relatively low. Asthma comorbidity, exacerbation history, severe bronchial-obstruction, smoking status and a spirometry-confirmed COPD diagnosis were significantly associated with ICS prescription.Taylor & Francis Ltd20162016-01-0120162016-01-01research articlehttp://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.13003/10515reponame:Docusalutinstname:Conselleria de Salut i Consum del Govern de les Illes BalearsInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:docusalut.com:20.500.13003/105152026-06-22T12:44:07Z
dc.title.none.fl_str_mv Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain)
title Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain)
spellingShingle Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain)
Román-Rodríguez, Miguel
Administration, Inhalation
Male
Aged, 80 and over
Asthma
Aged
Dose-Response Relationship, Drug
Spain
Adrenal Cortex Hormones
Pulmonary Disease, Chronic Obstructive
Humans
Smoking
Middle Aged
Cross-Sectional Studies
Spirometry
Primary Health Care
Regression Analysis
Female
Multivariate Analysis
Aged, 80 and over
Femenino
Análisis Multivariante
Administración por Inhalación
Masculino
Fumar
Estudios Transversales
Enfermedad Pulmonar Obstructiva Crónica
Relación Dosis-Respuesta a Droga
Humanos
Persona de Mediana Edad
Anciano
Asma
Anciano de 80 o más Años
Corticoesteroides
Atención Primaria de Salud
Análisis de Regresión
Espirometría
España
Chronic obstructive pulmonary disease
treatment
inhaled corticosteroids
primary care
quality of healthcare
title_short Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain)
title_full Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain)
title_fullStr Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain)
title_full_unstemmed Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain)
title_sort Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain)
dc.creator.none.fl_str_mv Román-Rodríguez, Miguel
van Boven, Job F. M.
Vargas, Freya
Contreras, Cecilia C.
Lamelas, Gema
Gestoso, Salvador
Gongora, Miguel
Corredor Ibáñez, María Teresa
Esteva Cantó, Magdalena
author Román-Rodríguez, Miguel
author_facet Román-Rodríguez, Miguel
van Boven, Job F. M.
Vargas, Freya
Contreras, Cecilia C.
Lamelas, Gema
Gestoso, Salvador
Gongora, Miguel
Corredor Ibáñez, María Teresa
Esteva Cantó, Magdalena
author_role author
author2 van Boven, Job F. M.
Vargas, Freya
Contreras, Cecilia C.
Lamelas, Gema
Gestoso, Salvador
Gongora, Miguel
Corredor Ibáñez, María Teresa
Esteva Cantó, Magdalena
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv
dc.subject.none.fl_str_mv Administration, Inhalation
Male
Aged, 80 and over
Asthma
Aged
Dose-Response Relationship, Drug
Spain
Adrenal Cortex Hormones
Pulmonary Disease, Chronic Obstructive
Humans
Smoking
Middle Aged
Cross-Sectional Studies
Spirometry
Primary Health Care
Regression Analysis
Female
Multivariate Analysis
Aged, 80 and over
Femenino
Análisis Multivariante
Administración por Inhalación
Masculino
Fumar
Estudios Transversales
Enfermedad Pulmonar Obstructiva Crónica
Relación Dosis-Respuesta a Droga
Humanos
Persona de Mediana Edad
Anciano
Asma
Anciano de 80 o más Años
Corticoesteroides
Atención Primaria de Salud
Análisis de Regresión
Espirometría
España
Chronic obstructive pulmonary disease
treatment
inhaled corticosteroids
primary care
quality of healthcare
topic Administration, Inhalation
Male
Aged, 80 and over
Asthma
Aged
Dose-Response Relationship, Drug
Spain
Adrenal Cortex Hormones
Pulmonary Disease, Chronic Obstructive
Humans
Smoking
Middle Aged
Cross-Sectional Studies
Spirometry
Primary Health Care
Regression Analysis
Female
Multivariate Analysis
Aged, 80 and over
Femenino
Análisis Multivariante
Administración por Inhalación
Masculino
Fumar
Estudios Transversales
Enfermedad Pulmonar Obstructiva Crónica
Relación Dosis-Respuesta a Droga
Humanos
Persona de Mediana Edad
Anciano
Asma
Anciano de 80 o más Años
Corticoesteroides
Atención Primaria de Salud
Análisis de Regresión
Espirometría
España
Chronic obstructive pulmonary disease
treatment
inhaled corticosteroids
primary care
quality of healthcare
description Background: There is a worldwide over-prescription of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD), off-label prescribing, and unnecessary prescription of high doses. Objectives: Our aim was to assess the prescription rate of ICS and to identify sociodemographic and clinical factors associated with ICS prescription among patients with COPD, treated in Balearic primary healthcare. Methods: This cross-sectional study included all patients with a clinical COPD diagnosis, who attended a primary care centre of the Balearic Islands (Spain) during 2012. Also, a sub-population with spirometry-confirmed COPD was defined. Data were obtained on patient demographics, smoking status, spirometry, ICS prescriptions, other respiratory medication, exacerbations and comorbidities. Associations with ICS and high-dose ICS prescription were assessed using multivariate regression analyses. Results: In total, 15,440 patients were included (70% men, mean age 68.6 years), and 44.6% were prescribed ICS. The largest association with ICS prescription was asthma comorbidity (OR: 3.50; 95%CI: 3.12-3.92), followed by exacerbation history (OR: 2.23; 95%CI: 2.07-2.47). In addition, smoking status, spirometry, atopic dermatitis, allergic rhinitis and mean age were significantly (P<0.001) associated with ICS treatment. In the spirometry-confirmed population, asthma (OR: 2.89; 95%CI: 2.29-3.64) and exacerbations were also the major factors (OR: 2.85; 95%CI: 2.45-3.32) followed by severe bronchial-obstruction (OR: 2.63; 95%CI: 2.24-3.08). High-dose ICS prescription was mainly associated with severe obstruction (OR: 2.27; 95%CI: 1.93-2.68). Conclusion: The percentage of COPD patients prescribed ICS in Balearic primary care is relatively low. Asthma comorbidity, exacerbation history, severe bronchial-obstruction, smoking status and a spirometry-confirmed COPD diagnosis were significantly associated with ICS prescription.
publishDate 2016
dc.date.none.fl_str_mv 2016
2016-01-01
2016
2016-01-01
dc.type.none.fl_str_mv research article
http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/20.500.13003/10515
url https://hdl.handle.net/20.500.13003/10515
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Taylor & Francis Ltd
publisher.none.fl_str_mv Taylor & Francis Ltd
dc.source.none.fl_str_mv reponame:Docusalut
instname:Conselleria de Salut i Consum del Govern de les Illes Balears
instname_str Conselleria de Salut i Consum del Govern de les Illes Balears
reponame_str Docusalut
collection Docusalut
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411632054009856
score 15.811543